Beryl Manning-Geist, MD

Emory SOM Faculty | Memorial Sloan Kettering Gynecologic Oncology Fellow | Harvard OB-GYN | Views are my own

[Beryl Manning-Geist, MD @Doctor_Beryl]

@agz_eriksson @Oslounivsykehus @YunWang41041765 @ESGO_society @UniOslo_MED @OncoAlert @BjerreTrent @KatharinaBisch5 Yahoo! Congrats, what a lucky department!

[Beryl Manning-Geist, MD @Doctor_Beryl]

A privilege to provide commentary in @gynoncjnls on how we leverage the folate receptor to treat gynecologic malignancy. It’s time to outsmart cancer! @WinshipAtEmory

https://t.co/ckWl69DuoU

[Beryl Manning-Geist, MD @Doctor_Beryl]

It’s standing room only at @WinshipAtEmory combined GYN onc and surg onc journal club as we refine our evidence-based #HIPEC protocol for #ovariancancer patients at Emory

@SusanModesitt @jscalici @s_illey @SethConcorsMD

[Beryl Manning-Geist, MD @Doctor_Beryl]

Still beaming from the magic that was the @nycmarathon in the city I love so very much

🏃🏼‍♀️🏃🏼‍♀️🏃🏼‍♀️

[Beryl Manning-Geist, MD @Doctor_Beryl]

My better half, Ryan Langdale of @TheChartisGroup, quoted in the @WSJ on consolidation in the cancer industry.

https://t.co/h5hYQjyxeb

[Beryl Manning-Geist, MD @Doctor_Beryl]

@DmitriyZamarin @MountSinaiNYC @StephanieVBlank Congrats @DmitriyZamarin! You’re doing amazing things!

[Beryl Manning-Geist, MD @Doctor_Beryl]

Excited to be named an early career new investigator by NRG oncology! Can’t wait to bring more of these #clinicaltrials to our patients at @WinshipAtEmory @EmoryGynOb

https://t.co/27fyHfbbqw

[Beryl Manning-Geist, MD @Doctor_Beryl]

Our newest editorial is out now—bravo to #SENECA investigators for their collaborative effort. Excited to see what we can do with this database to improve our clinical care!

[IJGC @IJGConline]

#Editorial on #SENECA study @SENECAStudy
@ https://t.co/gQCc44LpnW
#SLNmapping #EndometrialCancer
@Quique_ChC @ClinicaNavarra @JennyMueller @Doctor_Beryl

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @Frumovitz @HousseinELHAJJ3 @AinhoaMada @Jc_vilches @erodriguezglez @daggezmine @astraubhar

#WeeklyPodcast #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

[Beryl Manning-Geist, MD @Doctor_Beryl]

Had a wonderful time joining @TuftsObGynRes on behalf of @EmoryGynOb to kick off this year’s Tufts OB/GYN grand rounds and talking about #fertility in #endometrialcancer

[Beryl Manning-Geist, MD @Doctor_Beryl]

@DrKatyMoore Thanks for the shout out @NCCH_MD and YES @DrKatyMoore. I’d advocate for earlier in treatment course given toxicity profile and therapeutic benefit of FR targeting ADCs compared to traditional cytotoxics!

[Beryl Manning-Geist, MD @Doctor_Beryl]

Antibody drug conjugates are an exciting new therapy, but so far targeting folate receptor + ovarian cancer is limited to high grade. Here, we show that low grade ovarian cancers have the same % of folate receptor positivity. Next up: see if these treatments benefit patients!

[Team Ovary, Memorial Sloan Kettering Cancer Center @TeamOvary_MSK]

Wonderful new paper out from @Doctor_Beryl evaluating folate receptor alpha expression in low grade serous ovarian cancer. A biomarker-driven approach to treatment selection is promising. @TeamOvary_MSK @TeamEndo_MSK

https://t.co/5eDJUKroyL

[Winship Cancer Institute of Emory University @WinshipAtEmory]

Newly arrived Winship gynecologic oncologist Beryl Manning-Geist, MD, kicks off the next session with a talk on targeted and hormone therapy options for treating low-grade epithelial ovarian cancer. #DDHO2024

[Winship Cancer Institute of Emory University @WinshipAtEmory]

A wonderful gynecologic cancer session comes to a close with a panel discussion and patient case presentation with all of our speakers. #DDHO2024

[Beryl Manning-Geist, MD @Doctor_Beryl]

@DNasioudis @gynoncjnls 👏👏👏

[Beryl Manning-Geist, MD @Doctor_Beryl]

@TeresaBoitano @David_Cohn_MD Forever trying to infiltrate that UAB fam 😘

[Beryl Manning-Geist, MD @Doctor_Beryl]

Thrilled to participate in the editorial process, learn from the greats @David_Cohn_MD and work to bring forward advancements in GYN cancer care!

[@GynOncJnls @gynoncjnls]

‼️ New editorial 📄 program initiative between @gynoncjnls and #BRIDGES 🌉 scholars 👏 @SGO_org @GYNCancer @GOG @David_Cohn_MD @Doctor_Beryl @MMAlHilli @sy_rachel @LAURAJMOULTON @DNasioudis

[Beryl Manning-Geist, MD @Doctor_Beryl]

@uppals @IJGConline @pedroramirezMD @JennyMueller_ Super kind feedback @uppals
Thank you for listening & can’t wait for this work to reach bedside!

[Beryl Manning-Geist, MD @Doctor_Beryl]

Podcast “debut” with @IJGConline on our work on ovarian preservation in patients with #endometrialcancer. Always a fun time with @pedroramirezMD and @JennyMueller_

[MSKCC Team Uterus @TeamEndo_MSK]

What role does molecular subtyping play in guiding ovarian preservation in endometrial cancer❓❓Check this highly anticipated podcast by Dr. Mueller and @Doctor_Beryl @MSKCancerCenter #gyncsm #gyn

[Beryl Manning-Geist, MD @Doctor_Beryl]

@Pllcg3 @MSKCancerCenter @drpeterkingham Congrats!

[Beryl Manning-Geist, MD @Doctor_Beryl]

@SamLeiteMD Get to know your co-interviewees, they’ll be your colleagues for life! Best of luck!